Literature DB >> 24136736

Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects.

Lindsey M Negrete1, Michael S Middleton, Lisa Clark, Tanya Wolfson, Anthony C Gamst, Jessica Lam, Chris Changchien, Ivan M Deyoung-Dominguez, Gavin Hamilton, Rohit Loomba, Jeffrey Schwimmer, Claude B Sirlin.   

Abstract

PURPOSE: To prospectively describe magnitude-based multi-echo gradient-echo hepatic proton density fat fraction (PDFF) inter-examination precision at 3 Tesla (T).
MATERIALS AND METHODS: In this prospective, Institutional Review Board-approved, Health Insurance Portability and Accountability Act (HIPAA) compliant study, written informed consent was obtained from 29 subjects (body mass indexes > 30 kg/m2). Three 3T MRI examinations were obtained over 75-90 min. Segmental, lobar, and whole liver PDFF were estimated (using three, four, five, or six echoes) by magnitude-based multi-echo MRI in colocalized regions of interest. For estimate (using three, four, five, or six echoes), at each anatomic level (segmental, lobar, whole liver), three inter-examination precision metrics were computed: intra-class correlation coefficient (ICC), standard deviation (SD), and range.
RESULTS: Magnitude-based PDFF estimates using each reconstruction method showed excellent inter-examination precision for each segment (ICC ≥ 0.992; SD ≤ 0.66%; range ≤ 1.24%), lobe (ICC ≥ 0.998; SD ≤ 0.34%; range ≤ 0.64%), and the whole liver (ICC = 0.999; SD ≤ 0.24%; range ≤ 0.45%). Inter-examination precision was unaffected by whether PDFF was estimated using three, four, five, or six echoes.
CONCLUSION: Magnitude-based PDFF estimation shows high inter-examination precision at segmental, lobar, and whole liver anatomic levels, supporting its use in clinical care or clinical trials. The results of this study suggest that longitudinal hepatic PDFF change greater than 1.6% is likely to represent signal rather than noise.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  PDFF; inter-examination precision; magnitude-based MRI; proton density fat fraction; steatosis

Mesh:

Year:  2013        PMID: 24136736      PMCID: PMC3984359          DOI: 10.1002/jmri.24284

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  14 in total

1.  In vivo characterization of the liver fat ¹H MR spectrum.

Authors:  Gavin Hamilton; Takeshi Yokoo; Mark Bydder; Irene Cruite; Michael E Schroeder; Claude B Sirlin; Michael S Middleton
Journal:  NMR Biomed       Date:  2010-12-12       Impact factor: 4.044

2.  T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis.

Authors:  Catherine D G Hines; Alex Frydrychowicz; Gavin Hamilton; Dana L Tudorascu; Karl K Vigen; Huanzhou Yu; Charles A McKenzie; Claude B Sirlin; Jean H Brittain; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

3.  Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.

Authors:  Geraldine H Kang; Irene Cruite; Masoud Shiehmorteza; Tanya Wolfson; Anthony C Gamst; Gavin Hamilton; Mark Bydder; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-07-18       Impact factor: 4.813

4.  Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.

Authors:  Z Permutt; T-A Le; M R Peterson; E Seki; D A Brenner; C Sirlin; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2012-05-03       Impact factor: 8.171

5.  Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy.

Authors:  Sina Meisamy; Catherine D G Hines; Gavin Hamilton; Claude B Sirlin; Charles A McKenzie; Huanzhou Yu; Jean H Brittain; Scott B Reeder
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

Review 6.  Imaging-based quantification of hepatic fat: methods and clinical applications.

Authors:  Xiaozhou Ma; Nagaraj-Setty Holalkere; Avinash Kambadakone R; Mari Mino-Kenudson; Peter F Hahn; Dushyant V Sahani
Journal:  Radiographics       Date:  2009 Sep-Oct       Impact factor: 5.333

7.  Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.

Authors:  Takeshi Yokoo; Mark Bydder; Gavin Hamilton; Michael S Middleton; Anthony C Gamst; Tanya Wolfson; Tarek Hassanein; Heather M Patton; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2009-02-12       Impact factor: 11.105

8.  Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial.

Authors:  Thuy-Anh Le; Joshua Chen; Christopher Changchien; Michael R Peterson; Yuko Kono; Heather Patton; Benjamin L Cohen; David Brenner; Claude Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

9.  Role of Body Mass Index, Waist-to-Height and Waist-to-Hip Ratio in Prediction of Nonalcoholic Fatty Liver Disease.

Authors:  Rui-Dan Zheng; Zhuo-Ran Chen; Jian-Neng Chen; Yan-Hui Lu; Jie Chen
Journal:  Gastroenterol Res Pract       Date:  2012-05-31       Impact factor: 2.260

10.  Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease.

Authors:  M S Mirza
Journal:  ISRN Gastroenterol       Date:  2011-08-28
View more
  25 in total

1.  Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.

Authors:  Kevin A Zand; Amol Shah; Elhamy Heba; Tanya Wolfson; Gavin Hamilton; Jessica Lam; Joshua Chen; Jonathan C Hooker; Anthony C Gamst; Michael S Middleton; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2015-04-03       Impact factor: 4.813

2.  Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease.

Authors:  N Y Yu; T Wolfson; M S Middleton; G Hamilton; A Gamst; J E Angeles; J B Schwimmer; C B Sirlin
Journal:  Clin Radiol       Date:  2017-01-05       Impact factor: 2.350

Review 3.  Fat Quantification in the Abdomen.

Authors:  Cheng William Hong; Soudabeh Fazeli Dehkordy; Jonathan C Hooker; Gavin Hamilton; Claude B Sirlin
Journal:  Top Magn Reson Imaging       Date:  2017-12

4.  Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis.

Authors:  Michael S Middleton; Elhamy R Heba; Catherine A Hooker; Mustafa R Bashir; Kathryn J Fowler; Kumar Sandrasegaran; Elizabeth M Brunt; David E Kleiner; Edward Doo; Mark L Van Natta; Joel E Lavine; Brent A Neuschwander-Tetri; Arun Sanyal; Rohit Loomba; Claude B Sirlin
Journal:  Gastroenterology       Date:  2017-06-15       Impact factor: 22.682

5.  Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis.

Authors:  Janki Patel; Ricki Bettencourt; Jeffrey Cui; Joanie Salotti; Jonathan Hooker; Archana Bhatt; Carolyn Hernandez; Phirum Nguyen; Hamed Aryafar; Mark Valasek; William Haufe; Catherine Hooker; Lisa Richards; Claude B Sirlin; Rohit Loomba
Journal:  Therap Adv Gastroenterol       Date:  2016-07-05       Impact factor: 4.409

Review 6.  Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Ma Ai Thanda Han; Rola Saouaf; Walid Ayoub; Tsuyoshi Todo; Edward Mena; Mazen Noureddin
Journal:  Expert Rev Clin Pharmacol       Date:  2017-03-09       Impact factor: 5.045

Review 7.  Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.

Authors:  Takeshi Yokoo; Suraj D Serai; Ali Pirasteh; Mustafa R Bashir; Gavin Hamilton; Diego Hernando; Houchun H Hu; Holger Hetterich; Jens-Peter Kühn; Guido M Kukuk; Rohit Loomba; Michael S Middleton; Nancy A Obuchowski; Ji Soo Song; An Tang; Xinhuai Wu; Scott B Reeder; Claude B Sirlin
Journal:  Radiology       Date:  2017-09-11       Impact factor: 11.105

8.  Evaluation of Quantitative Imaging Biomarkers for Early-phase Clinical Trials of Steatohepatitis in Adolescents.

Authors:  Nidhi P Goyal; Mary Catherine Sawh; Patricia Ugalde-Nicalo; Jorge E Angeles; James A Proudfoot; Kimberly P Newton; Michael S Middleton; Claude B Sirlin; Jeffrey B Schwimmer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-01       Impact factor: 2.839

9.  Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom.

Authors:  Diego Hernando; Samir D Sharma; Mounes Aliyari Ghasabeh; Bret D Alvis; Sandeep S Arora; Gavin Hamilton; Li Pan; Jean M Shaffer; Keitaro Sofue; Nikolaus M Szeverenyi; E Brian Welch; Qing Yuan; Mustafa R Bashir; Ihab R Kamel; Mark J Rice; Claude B Sirlin; Takeshi Yokoo; Scott B Reeder
Journal:  Magn Reson Med       Date:  2016-04-15       Impact factor: 4.668

Review 10.  Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.

Authors:  Yingzhen N Zhang; Kathryn J Fowler; Gavin Hamilton; Jennifer Y Cui; Ethan Z Sy; Michelle Balanay; Jonathan C Hooker; Nikolaus Szeverenyi; Claude B Sirlin
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.